DICE Therapeutics (NASDAQ:DICE) reported quarterly losses of $(0.58) per share.
Amrep Q2 EPS $0.68 Up From $0.45 YoY, Sales $16.15M Down From $16.24M YoY
Amrep (NYSE:AXR) reported quarterly earnings of $0.68 per share. This is a 51.11 percent increase over earnings of $0.45 per share from the same period last year. The company reported $16.15 million in sales this